Abramson Cancer Center ( Site 0107) — Philadelphia, Pennsylvania

Abramson Cancer Center ( Site 0107) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center ( Site 0107) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center ( Site 0107)?

Abramson Cancer Center ( Site 0107) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center ( Site 0107) conducted?

Abramson Cancer Center ( Site 0107) has 1 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma.

Is Abramson Cancer Center ( Site 0107) accredited by Crixeo Health?

Abramson Cancer Center ( Site 0107) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center ( Site 0107)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.